We are live on ! Find out more
BNGO icon

Bionano Genomics

143 hedge funds and large institutions have $176M invested in Bionano Genomics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $4.27M | Put options by funds: $1.84M

67% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 30

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

20% more capital invested

Capital invested by funds: $146M → $176M (+$29M)

2% more funds holding

Funds holding: 140143 (+3)

0% more ownership

Funds ownership: 0.05%0.05% (+0%)

Holders
143
Holders Change
+3
Holders Change %
+2.14%
% of All Funds
2.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
50
Reduced
30
Closed
19
Calls
$4.27M
Puts
$1.84M
Net Calls
+$2.42M
Net Calls Change
-$1.17M
Name Holding Trade Value Shares
Change
Change in
Stake
ACS
51
Archford Capital Strategies
Illinois
$116K
Zurich Cantonal Bank
52
Zurich Cantonal Bank
Switzerland
$107K +$13.8K +11 +10%
Principal Financial Group
53
Principal Financial Group
Iowa
$97.9K +$7.55K +6 +6%
TSS
54
Two Sigma Securities
New York
$94.8K +$136K +108 New
American Century Companies
55
American Century Companies
Missouri
$93.3K +$60.4K +48 +81%
BCM
56
Brookstone Capital Management
Illinois
$92.3K
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$92K +$1.26K +1 +1%
Osaic Holdings
58
Osaic Holdings
Arizona
$88.3K +$26.4K +21 +26%
VI
59
Versor Investments
New York
$86.6K -$127K -101 -51%
PTP
60
Platform Technology Partners
New York
$83.5K +$51.6K +41 +76%
Janus Henderson Group
61
Janus Henderson Group
United Kingdom
$82.4K -$120K -95 -50%
AGM
62
Alpine Global Management
New York
$80K +$80.5K +64 +237%
Simplex Trading
63
Simplex Trading
Illinois
$74K +$107K +85 New
EGM
64
Engineers Gate Manager
New York
$72.6K +$104K +83 New
Commonwealth Equity Services
65
Commonwealth Equity Services
Massachusetts
$67K +$5.03K +4 +5%
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$67K +$85.6K +68 +680%
Rafferty Asset Management
67
Rafferty Asset Management
New York
$64.2K -$30.2K -24 -25%
ACM
68
Aquatic Capital Management
Illinois
$62K +$89.3K +71 New
CIM
69
CIM Investment Management
Pennsylvania
$61.2K +$32.7K +26 +59%
PAMS
70
Pictet Asset Management (Switzerland)
Switzerland
$61K +$45.3K +36 +106%
LPL Financial
71
LPL Financial
California
$56.7K -$7.55K -6 -8%
ProShare Advisors
72
ProShare Advisors
Maryland
$56.2K +$12.6K +10 +19%
AB
73
Amalgamated Bank
New York
$56K +$3.77K +3 +5%
OC
74
Oppenheimer & Co
New York
$55.1K -$2.52K -2 -3%
State of Wisconsin Investment Board
75
State of Wisconsin Investment Board
Wisconsin
$52.8K -$37.8K -30 -33%

BNGO Hedge Fund Activity: Q4 2022 in Review

143 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2022, worth a combined $176M — up 20% from $146M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BNGO positions and 19 closed out — a net gain of 4 holders — while 50 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $3.4M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.58M sold.

  • 143 institutional investors held Bionano Genomics (BNGO) as of Q4 2022, up from 140 in Q3 2022.
  • Funds reported $176M of Bionano Genomics stock for Q4 2022, up 20% quarter-over-quarter.
  • 23 funds opened new Bionano Genomics positions in Q4 2022 and 19 closed out, a net change of +4 holders.
  • The largest Bionano Genomics buyer in Q4 2022 was BlackRock, an estimated $3.4M added.
  • The largest Bionano Genomics seller in Q4 2022 was Renaissance Technologies, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2022.